Herein vi investigate whether leptin, adiponectin or their ratio (L/A ratio) could be associated with increased CVD risk in SCZ and BD, and in subgroups according to AP treatment, independent of other established cardio-metabolic risk factors. Here, LEP is linked to Behcet disease.